Family Health International
Durham, North Carolina, United States
Purpose
to support the phase III trial of long acting injectable drug, i.e., cabotegravir, for HIV prevention among women in sub-Saharan Africa
Division
Global Health
Date
June 2017
Region Served
AFRICA
Committed amount
$34,167,607
Grant topic
HIV
Duration (months)
84
Grantee location
Durham, North Carolina, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.